|

Sequent Extended Study

RECRUITINGSponsored by Fundación EPIC
Actively Recruiting
SponsorFundación EPIC
Started2023-03-28
Est. completion2026-06-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05788432

Summary

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Sequent Please Neo to meet EU Medical Device regulation (MDR) requirements in all the consecutive patients treated with Sequent Please Neo.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients treated with Sequent please neo according to routine hospital practice and following instruction for use.
* Informed Consent Signed.

Exclusion Criteria:

* Patient life expectancy less than 12 months.
* Contraindication for antiplatelet therapy.
* Not meet inclusion criteria.

Conditions3

Coronary Artery DiseaseHeart DiseaseIschemic Heart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.